Parkinson's Disease Dementia: Synergistic Effects of Alpha-Synuclein, Tau, Beta-Amyloid, and Iron

Parkinson's disease dementia (PDD) is a common complication of Parkinson's disease that seriously affects patients' health and quality of life. At present, the process and pathological mechanisms of PDD remain controversial, which hinders the development of treatments. An increasing number of clinical studies have shown that alpha-synuclein (alpha-syn), tau, beta-amyloid (A beta), and iron are closely associated with PDD severity. Thus, we inferred the vicious cycle that causes oxidative stress (OS), due to the synergistic effects of alpha-syn, tau, A beta, and, iron, and which plays a pivotal role in the mechanism underlying PDD. First, iron-mediated reactive oxygen species (ROS) production can lead to neuronal protein accumulation (e.g., alpha-syn and A beta) and cytotoxicity. In addition, regulation of post-translational modification of alpha-syn by iron affects the aggregation or oligomer formation of alpha-syn. Iron promotes tau aggregation and neurofibrillary tangles (NFTs) formation. High levels of iron, alpha-syn, A beta, tau, and NFTs can cause severe OS and neuroinflammation, which lead to cell death. Then, the increasing formation of alpha-syn, A beta, and NFTs further increase iron levels, which promotes the spread of alpha-syn and A beta in the central and peripheral nervous systems. Finally, iron-induced neurotoxicity promotes the activation of glycogen synthase kinase 3 beta (GSK3 beta) related pathways in the synaptic terminals, which in turn play an important role in the pathological synergistic effects of alpha-syn, tau and A beta. Thus, as the central factor regulating this vicious cycle, GSK3 beta is a potential target for the prevention and treatment of PDD; this is worthy of future study.

Automated summary

Parkinson's disease dementia is a common complication of Parkinson's disease that seriously affects patients' health and quality of life. The complex interplay of iron, alpha-synuclein, tau, beta-amyloid, and oxidative stress plays a pivotal role in the mechanism underlying PDD, leading to neuronal protein accumulation, neuroinflammation, and cell death. GSK3 beta is identified as a potential target for the prevention and treatment of PDD due to its central role in regulating the vicious cycle of molecular interactions.